Related by context. All words. (Click for frequent words.) 65 Study Demonstrates 65 PHASE III 65 DIAGNOSTIC 65 Prospective Randomized 64 Demonstrates Significant 64 HALTS 64 Initiates Clinical Trial 64 CANCER TREATMENT 63 IN PATIENTS WITH 63 Percutaneous Tibial Nerve Stimulation 63 Study Evaluating 63 Observational Study 63 FDA Approvals 63 Tyrosine Kinase Inhibitor 63 DIAGNOSTICS 63 Preclinical Study 63 STEM CELL 62 IND Application 62 STENT 62 MOLECULAR 62 THERAPEUTIC 62 ONCOLOGY 62 Novel Compound 62 Novel Inhibitor 62 Biomarker Study 62 PROGRAM FOR 62 VASCULAR 62 First Patient Enrolled 62 Significantly Improves 62 THAT ARE DIFFICULT TO 62 Clinical Evaluation 61 Demonstrates Positive 61 Schizophrenia Treatment 61 EXPANSION OF 61 TECHNOLOGIST 61 Drug Candidate 61 Risk Stratification 61 Announce Collaboration Agreement 61 AUDIO PROVIDED BY 61 Phase Ib Clinical Trial 61 Prolongs Survival 61 Contrast Agent 61 THE ADOPTION OF 61 TREATMENT FOR 61 Diagnostic Tests 61 HYPERTENSION 61 Acute Myocardial Infarction 60 BIOMEDICAL 60 Bosutinib 60 FDA Clears 60 Combination Treatment 60 FLU VACCINE 60 Potent Inhibitor 60 Shows Statistically Significant 60 Improves Quality 60 Clinical Outcome 60 Prospective Multicenter 60 ASSOCIATE DIRECTOR 60 Carotid Artery Stenting 60 Eur J 60 J Clin 60 Left Ventricular 60 Protein Expression 60 REMINDER ORLive Presents 59 CURRICULUM 59 Heart Failure Patients 59 Non Invasive 59 COLLABORATIVE 59 Oral Fingolimod 59 FOR FAMILIES 59 Meta Analysis 59 Aortic Dissection 59 Significantly Improved 59 Diabetic Neuropathy 59 Carotid 59 Improves Survival 59 PHYSICIANS 59 JOURNAL OF 59 Chronic Heart Failure 59 orally inhaled migraine 59 Successfully Completes Phase 59 Endovascular Repair 59 Adjuvant Treatment 59 Treatment Outcome 59 Non Invasive Treatment 59 THYROID 58 LUNG CANCER 58 Intervention Trial 58 Proven Effective 58 Analytical Tool 58 FOR PATIENTS 58 Oral Mucositis 58 NEW WAY TO 58 FOR HEALTH 58 Phase 2b Study 58 CABANA 58 Prognostic 58 Curr Opin 58 SKIN CANCER 58 Clinical Efficacy 58 Combo Therapy 58 ID Seq 58 Noninvasive Prenatal 58 MEDICATIONS 58 Less Invasive 58 Anticancer Agent 58 Improves Outcomes 58 Prognostic Value 58 Detection Device 58 Pharmacokinetic Study 58 Proc Am Soc 58 Therapeutic Antibody 58 Study Shows Significant 58 NDA Submission 57 Combination Therapy 57 Dilated Cardiomyopathy 57 PICKED FOR 57 TAKES OUT 57 EXTENDING THE 57 DRUG DISCOVERY 57 Phase 1b Clinical Trial 57 Diagnostic Tools 57 Peripheral Arterial 57 INFORMATICS 57 Nuclear Receptors 57 'S #TH [002] 57 Anti Tumor 57 Aurora Kinase 57 Score TOS 57 Surgical Treatment 57 OF EXCELLENCE 57 Plus Ribavirin 57 Carotid Stenting 57 Anticancer Drug 57 Fungal Infections 57 HEALTH SYSTEM 57 MEMORIAL SERVICE FOR 57 LIFE SCIENCE 57 FDA Okays 57 Targeted Therapy 57 Crit Rev 57 FDA Clearance 57 FOR EDUCATION 57 Medoxomil 57 Ischemic Stroke 57 Knee Osteoarthritis 57 Endovascular System 57 Ranolazine 57 Companion Diagnostic 57 OF CHOICE 57 Patients Receiving 57 Demonstrates Efficacy 57 PROCEED 57 Neoadjuvant Chemotherapy 57 Pooled Analysis 57 PARKINSON 'S DISEASE 57 Transdermal Patch 57 LEUKEMIA 56 Cardiol 56 AMYLIN 56 See CLINICAL PHARMACOLOGY 56 Endocrinol 56 CURE FOR 56 #-# Full Text 56 Protein Biomarker 56 Oral Formulation 56 Randomized Clinical Trials 56 Demonstrates Statistically Significant 56 Molecular Mechanism 56 Lupus Drug 56 Minimally Invasive Treatment 56 Progenitor Cells 56 Investigational Drug 56 Left Atrial 56 Investigational Agent 56 Randomized Evaluation 56 Immunomodulatory 56 Adverse Event 56 #:#-# [024] 56 GOES GLOBAL 56 Gene Expression Analysis 56 Intervention Effectiveness 56 RELEVANCE 56 Hepatic Encephalopathy 56 Placebo Controlled Trial 56 WYETH 56 Secondary Hyperparathyroidism 56 Intravascular 56 JAK Inhibitor 56 Subgroup Analysis 56 Acute Heart Failure 56 Dendritic Cell 56 Lipid Lowering 56 STUDENTS GET 56 CARDIAC 56 Treated Patients 56 Skin Irritation 56 Symptom Severity 56 SICKLE CELL 56 Benign Prostatic Hyperplasia 56 Teva Provides Update 56 Rheumatoid Arthritis Drug 56 Contrast Agents 56 Myocardial Ischemia 56 Mimetics 56 GROWS IN 56 Clinical Outcomes 56 Recurrent Breast Cancer 55 Valve Replacement 55 Long Term Efficacy 55 Adjuvant Therapy 55 RADIOLOGY 55 Breast Cancer Recurrence 55 'S ABILITY TO 55 Cardiac Troponin 55 MICROSCOPE 55 Infarct 55 Int J 55 Prevent Stroke 55 CONTRAINDICATIONS 55 Single Dose 55 Therapy Reduces 55 Intrathecal 55 Orthostatic Hypotension 55 Cyclooxygenase 2 55 Pelvic Organ Prolapse 55 Adjuvant Colon Cancer 55 TO EDUCATE 55 Circulating Tumor Cells 55 Clinical Validation 55 Neurosurg 55 Capillary Electrophoresis 55 Helps Predict 55 Obstet Gynecol 55 Enters Beta 55 Shows Promise Against 55 TRADITION OF 55 Proves Effective 55 Leukocyte 55 Intervention Effectiveness CATIE 55 WOMEN WITH 55 Systematic Review 55 Image Guided 55 HCV Protease Inhibitor 55 Lifestyle Intervention 55 transcranial Doppler ultrasound 55 ASTEROID 55 Nicotine Vaccine 55 Hyperlipidemia 55 Magnetic Stimulation 55 Roche COBAS 55 Treating Chronic 55 Mouth Rinse 55 Induction Therapy 55 Novel Therapeutic 55 Node Positive 55 FUTURE OF 55 GUIDE FOR 55 Immunogenicity 55 Companion Diagnostics 55 LOST HIS 55 PET Scanner 55 Proves Successful 55 TO SPEAK ON 55 pan histone deacetylase 55 RNAi Therapeutic 55 Heart Failure Therapy 55 Placebo Controlled 55 FORUM ON 55 Drug Shows Promise 55 Reflux Disease 54 Pediatric Patients 54 Diabetic Nephropathy 54 CONTINUING EDUCATION 54 AGAINST CANCER 54 Systemic Sclerosis 54 Dose Response 54 Quantitation 54 Autologous Stem Cell Transplantation 54 Symptom Scale 54 Guideline Update 54 Beta Blocker 54 Vertebral Fracture 54 Severe Asthma 54 Cinacalcet 54 Node Negative 54 Oral Glucose Tolerance 54 Oral Fluid 54 Diagnostic Criteria 54 Renal Function 54 Hernia Repair 54 Stable Angina 54 Maven Semantic 54 Randomized Trials 54 Targeted Therapies 54 Further Validates 54 Hepatitis C Treatment 54 FIBROMYALGIA 54 Efficacy Trial 54 RECOGNITION FOR 54 Refractory Angina 54 Plasma Protein 54 #:#-# [023] 54 HEART HEALTH 54 Pharmacogenetic 54 Low Dose 54 J Pediatr 54 Cholesterol Lowering Drug 54 Novel Treatments 54 VerifyNow 54 Optical Coherence Tomography 54 Vascular Ultrasound 54 Pregnancy Outcomes 54 AND SERVE 54 Aromatase Inhibitors 54 PUT AN 54 Molecular Basis 54 Oligonucleotides 54 Roche AmpliChip 54 Develop Innovative 54 Bosentan 54 Stent Placement 54 Unfractionated Heparin 54 FAMILION 54 AND YOUTH 54 Microvolt T Wave Alternans 54 Immunohistochemistry 54 Therapy Shows Promise 54 Exp Clin 54 BIPOLAR 54 SENATE APPROVES 54 Proteasome 54 Therapeutic Potential 54 Hypercholesterolemia 54 MEETING PREVIEW 54 Hormone Receptor Positive 54 Suicidality 54 Test Detects 54 Coronary Arteries 54 Cell Differentiation 54 C Reactive Protein 54 Lung Tumors 54 Differential Diagnosis 53 Slow Progression 53 PEDIATRICS 53 Results Confirm 53 Psoriasis Drug 53 Bipolar Depression 53 Glycemia 53 WHERE ARE WE 53 Platelet Function 53 Bone Mineral Density 53 Septic Shock 53 ATMOSPHERIC 53 SCIENCE AND 53 DNA Sequencer 53 Transvaginal 53 Implantable Device 53 Patient Registry 53 Clinical Trial Data 53 CANCER PATIENTS 53 Angiographic 53 Cancer Stem Cells 53 MARTENS 53 Randomized Controlled 53 Aliskiren 53 TOPICAL 53 Pharmacodynamic 53 Renal Insufficiency 53 Phenotyping 53 Hormone Refractory Prostate Cancer 53 Assay Kit 53 CLINICAL PHARMACOLOGY 53 Demonstrates Sustained 53 Survival Benefit 53 Study Casts Doubt 53 Highly Accurate 53 PROSTATE CANCER 53 CLEAN WATER 53 Bone Metastases 53 ALZHEIMER 53 Inhaled Corticosteroids 53 Cardiogenic Shock 53 Laryngeal Cancer 53 THROUGH ITS 53 STUDY FINDS 53 Gene Mutation 53 Warfarin Sensitivity 53 Clostridium difficile Infection 53 YOUR BRAIN 53 Vasc 53 Genetic Markers 53 Prostate Cancer Diagnosis 53 Psychol 53 VOLTAGE 53 Functional Assessment 53 Concussion Assessment 53 Statistically Significant 53 AdnaTest 53 Genetic Marker 53 Osteoporosis Treatment 53 J Consult Clin 53 Myocardial Perfusion 53 Interferon Alfa 53 Epitopes 53 Cytometry 53 Multicentre 53 Lowers Risk 53 Skin Cholesterol 53 Molecular Diagnostic 53 Cell Adhesion 53 Histological 53 Antipsychotic 53 Symptom Relief 53 Test Methodology 53 MORE EFFECTIVE 53 Estrogen Receptor 53 Protein Microarray 53 Disease Progression 53 Insulin Sensitivity 53 PROGRAM COORDINATOR 53 Treatment Regimen 53 Enzyme Linked 53 AWARENESS WEEK 53 Chemoradiation 53 NEW STUDY 53 ANN INTERN MED 52 Fasting Glucose 52 RALLY FOR 52 Tumor Angiogenesis 52 ImPACT Immediate Post 52 SOUTHERLY WINDS 52 #-# Abstract Full [002] 52 Prophylactic Treatment 52 Treating Depression 52 Anti Inflammatory Drug 52 Partial Nephrectomy 52 Multicenter Randomized Double 52 Clinical Guideline 52 Newly Identified 52 Breast Ultrasound 52 P#Y# [002] 52 Cardiac Marker 52 Phase III multicenter 52 ACTIVE IN 52 WALK TO 52 Diagnostic Accuracy 52 Virologic 52 Protein Interaction 52 CURVES 52 Arterial Disease 52 Moxifloxacin 52 PEGASYS ® 52 Whole Genome Sequencing 52 TO SHORE 52 COUNTING ON 52 Cardiovasc 52 Atopic Dermatitis 52 Paroxysmal 52 Pharmacogenetics 52 Breast Tissue 52 AurSCOPE 52 Antiangiogenic 52 Anti Inflammatory Drugs 52 Glaucoma Treatment 52 ANTI DRUG 52 Asthma Treatment 52 Systolic Blood Pressure 52 TB Vaccine 52 Daptomycin 52 CPT Codes 52 Genomic Analysis 52 Circulatory Support 52 Showed Significant 52 CytoSure 52 Molecular Mechanisms 52 Demonstrated Significant 52 Cardiometabolic 52 NEW BUILDING 52 Sequencing Systems 52 Individualized Therapy 52 Minimally Invasive Procedure 52 Blepharospasm 52 Screening Tool 52 Demonstrates Superior 52 Clinical Antipsychotic Trials 52 undergoing elective percutaneous 52 Reduced Risk 52 Invasive Fungal Infections 52 Lower Limb 52 Alkaline Phosphatase 52 Alpha interferons including 52 Therapeutic Efficacy 52 Platinol ® 52 Antitumor 52 Apoptotic 52 Virtual Colonoscopy 52 ARBITER 6 52 Non Inferiority 52 REAL ESTATE MARKET 52 Improve Outcomes 52 Motility 52 Novel Approach 52 Human Leukocyte Antigen 52 Neovascularization 52 Glaucoma Eye 52 PDUFA Date 52 J Appl 52 Cannabinoid 52 Neuromuscular Disorders 52 Effective Treatments 52 ADJUSTING TO 52 Clinical Documentation 52 Monotherapy 52 Posaconazole 52 Quadrivalent 52 Oncol 52 Post Herpetic Neuralgia 52 Post Operative 52 STABILITY OF 51 Protease Inhibitors 51 Treatment Algorithm 51 Gynecol Oncol 51 ACCELERATE 51 Artificial Pancreas 51 Kidney Function 51 Clinical Significance 51 Immunol 51 Visceral Fat 51 DISABILITIES 51 RELIGION NOTES 51 Antiepileptic Drug 51 Aortic Stenosis 51 BY CHLOE 51 Bioequivalence 51 LECTURES 51 Epilepsy Drug 51 Mouse Models 51 STUDY GROUP 51 AlloMap 51 Efficiently Manage 51 Alexion Soliris 51 CANCER RESEARCH 51 Treatment Reduces 51 Helps Diagnose 51 number NCT# ClinicalTrials.gov 51 Glucose Monitor 51 #:#-# [001] 51 Holds Promise 51 GILEAD 51 Asthma Intervention 51 Follicular Lymphoma 51 DO YOU BELIEVE IN 51 Could Predict 51 STEM CELLS 51 HER2 Positive 51 Fracture Risk 51 POISE 51 SensiGene 51 PUBLIC EDUCATION 51 Severity Scale 51 D Dimer 51 Unmet Medical 51 RE LY 51 Solution Accelerates 51 Protein Structure 51 ELISA assay 51 Study Showed 51 FOR CANCER 51 Services #:#-#,# Abstract 51 Lesion 51 OVARIAN CANCER 51 Prodrugs 51 Clin J 51 Protein Involved 51 Fewer Side Effects 51 FOR CHANGE 51 Imaging Techniques 51 SF #v# 51 Hematopoietic 51 Cognitive Problems 51 Therapeutic Antibodies 51 Lung Injury 51 Neuropathic 51 Genisphere 51 Predict Risk 51 Patients Suffering 51 Echocardiographic 51 AWARENESS MONTH 51 OSLER 51 Sleep Disturbances 51 Cell Signaling 51 Aggressive Reduction 51 Comput 51 Immunohistochemical 51 Bioavailability 51 PARP Inhibitor 51 Amplicor 51 Therapy Improves 51 Bronchodilator 51 Novel Antibody 51 KATRINA VICTIMS 51 Extracellular Matrix 51 Device Helps 51 Resequencing 51 Diabetic Foot Ulcers 51 Neuroprotection 51 BioElectronics Corporation Announces 51 Microalbuminuria 51 Severity MSCS score 51 Disord 51 POST RE HAB 51 Autoimmune Diseases 51 Cytotoxic 51 EVALUATION AND 50 Randomized Placebo Controlled Trial 50 Activated Checkpoint Therapy 50 Referenced EEG 50 SET FOR SATURDAY 50 Coronary CTA 50 Brain Tumor Therapy 50 Edge STudy 50 Mean Symptom Complex 50 Novel Approaches 50 Endpoints 50 Fulvestrant 50 Delayed Release Tablets 50 ENRICH 50 Arthritis Musculoskeletal 50 Epidemiological Studies Unit 50 Blood Pressure Drug 50 Tumor Microenvironment 50 Arch Neurol 50 Preclinical Evaluation 50 Therapeutic Approaches 50 Multicenter Phase 50 J Nutr 50 QT Prolongation 50 Deep Venous Thrombosis 50 Radiation Doses 50 Nucleic Acid Amplification 50 Could Revolutionize 50 ASSERT 50 SAFE RETURN 50 OUR WORLD 50 Improves Accuracy 50 Correlation Between 50 Geriatr 50 Viral Load 50 GLOBAL FUND 50 Significant Improvements 50 Fatty Liver 50 Immune Cell 50 UGT#A# 50 Theranostics 50 Metastatic Prostate Cancer 50 Outcomes Assessment 50 Interferon Gamma 50 Motherboard Benchmark Reviews 50 Infectious Disease Specialists 50 Osteoarthritis Patients 50 YOU DRIVE 50 Diabetes Res Clin 50 Reduces Pain 50 YOU CAN BE 50 Breast Density 50 Spinal Manipulation 50 Novel Therapeutics 50 ARTHRITIS 50 Tablet Formulation 50 Prognostic Factors 50 Glycemic Control 50 Postdoctoral Position 50 #:#-# [019] 50 zonisamide SR 50 SECRETS TO 50 HE4 50 Improve Patient Safety 50 BEST PRACTICES 50 Muscle Pain 50 ONSCREEN 50 NO MORE EXCUSES 50 Sipuleucel T 50 TALKIN ABOUT 50 Hematological Cancers 50 Crit Care 50 Abbott HUMIRA 50 Asthma COPD 50 FirstCyte 50 Vitro Diagnostic Multivariate 50 BY ANITA 50 Atypical Antipsychotics 50 Prognostic Index 50 Cardiac Function 50 BREAST CANCER AWARENESS 50 Drug Prevents 50 Immune Responses 50 LEGACY OF 50 Tumor Markers 50 Metastatic Renal Cell Carcinoma 50 Tumor Growth 50 Confirmatory 49 MAN DIED 49 PREVU x Point 49 Protein Interactions 49 Oropharyngeal 49 Prostate Cancer Risk 49 Signaling Pathways 49 VERONICA 'S 49 AND ECONOMIC 49 milnacipran HCl 49 EDUCATION PROGRAM 49 CellSearch ™ 49 Gastrointestinal Stromal Tumors 49 Small Bowel 49 Muscle Cells 49 Advanced Colorectal Cancer 49 RT PCR assay 49 Cognitive Impairment 49 Pharmacokinetic 49 AND WINE 49 GRAS Status 49 Capsules CII 49 Small Molecules 49 HOLINESS 49 Rehabil 49 Esophagitis 49 Hepatitis C Genotype 49 Helps Relieve 49 Main Outcome Measure 49 Psychiatric Services #:#-#,# 49 FOR AUTISM 49 Insulin Glargine 49 bronchial hyperresponsiveness 49 ALZHEIMER 'S ASSOCIATION 49 Pathogen Detection 49 CHARM Added 49 #:#-#,# CrossRef Medline [002] 49 Gene Variant 49 Genes Linked 49 Oxygen Saturation 49 MATH AND 49 RIVA D. 49 Protein Linked 49 WOMEN 'S BUSINESS 49 Investigator Initiated 49 Cervista HPV 49 THRIVES 49 CONFLICT RESOLUTION 49 Menstrual Pain 49 Demonstrate Significant 49 Diuretic 49 Myocardial 49 Rhinosinusitis 49 Gastrointestinal Disorders 49 ACE Inhibitors 49 Genes Associated 49 Self Efficacy 49 CHILDREN AND 49 Proliferative 49 Autoimmune Disease 49 AWARENESS DAY 49 Study Sheds Light 49 Hypertrophy 49 Rapid Detection 49 Epidermal 49 Medication Reconciliation 49 Treatment Shows Promise 49 Receptor Antagonists 49 HEALTH CENTER 49 PART OF OUR 49 REFLECTIONS OF 49 Pulmonary Artery 49 Ocular Inflammation 49 STRIDE PD 49 Rating Scale BPRS 49 Hybrid Capture 49 WATER BILLS 49 MITIGATION 49 Obese Teens 49 PREVU i 49 Vildagliptin 49 DNAwithPap R 49 Outcome Measures 49 TERANODE 49 Therapeutic Targets 49 LIBRARY 'S 49 TRADE NEWS Agilent Technologies 49 YOUR DREAMS 49 Gene Linked 49 Zicam Extreme 49 Pharmacokinetic PK 49 Low Density Lipoprotein Cholesterol 49 LEARNING DISABILITIES 49 HEALTH AND WELLNESS 49 BECAUSE YOUR 49 Alanine 49 Novel Peptide 49 CAPE FEAR 49 Cellular Therapies 49 DISTRICT 'S 49 Ion Channels 49 Longer Lasting 49 XIENCE V PROMUS Stent 49 Testing Methodology 48 Dyslipidemia 48 Profile SEP 48 Releases Podcast On 48 Immunologic 48 cTnI 48 Coronary Artery Bypass Surgery 48 Contraindications 48 Hepatotoxicity 48 Common Terminology Criteria 48 Abdominal Pain 48 Evaluation Program CTEP 48 Neurosci 48 Virus Linked 48 Radiation Treatment 48 Thymosin Beta 4 48 Enhanced Workflow 48 SIGN LANGUAGE 48 Drug Regimen 48 FRIAS 48 Non Responders 48 Liver Function 48 Standardized Assessment 48 NORTH CAROLINA WESLEYAN COLLEGE 48 ADVOCACY 48 neuronal nicotinic receptor NNR 48 Cognitive Abilities 48 Disorders Identification 48 RNA Interference 48 Blood Glucose 48 Multiple Myeloma Patients 48 Mammographic 48 #-# Abstract Full [001] 48 Clinical Decision Making 48 B Cell Lymphoma 48 Improve Diagnosis 48 KEY FACTS 48 NeuRx DPS RA 48 SUBSTANCE ABUSE 48 Desvenlafaxine Succinate 48 Glucose Control 48 Primary Endpoint 48 Nicotinic 48 Improve Quality 48 Extended Release Formulation 48 DANCE FOR 48 Significantly Reduced 48 Anthropometric 48 hemodynamic variables 48 GRANT WRITING 48 CANCER CARE 48 Pulmonary Function 48 FAITH CHRISTIAN 48 QD dosing 48 PREPARATORY 48 Treatment Algorithms 48 GENOME 48 MYCAMINE 48 Fibromyalgia Syndrome 48 OF THANKS 48 Inhibitory 48 Genetic Variation 48 Loading Dose 48 Improve Accuracy 48 Mitochondrial Dysfunction 48 MULTIPLE SCLEROSIS 48 Biologic Therapy 48 PLENARY 48 EVERLASTING 48 Fibrin Sealant 48 Rapid Antibody 48 Being Studied 48 Suboptimal 48 Biobehavioral 48 Incretin 48 HORIZONS AMI 48 Early Diagnosis 48 KOMEN 48 Scientists Unravel 48 Thrombophilia 48 PARKINSON 'S 48 HEALTHY LIFE 48 Cytotoxicity 48 methylation profiling 48 donepezil Aricept 48 Immunosuppression 48 #:#-#,# [003] 48 Infectivity 48 Ozarelix 48 Montgomery Åsberg Depression 48 Blood Glucose Meter 48 Transmembrane 48 Hormonal Contraceptives 48 Chemotherapy Improves 48 Tiotropium 48 Nat Rev 48 Neurodevelopmental 48 Maximum Likelihood 48 Enzymatic 48 Functional Outcomes 48 LungSign TM 48 NMR LipoProfile 48 BLINDED BY 48 Bioassay 48 IN FIGHT AGAINST 48 Cystatin C 48 Modifiable 48 Lipid Levels 48 Digit Symbol Substitution 48 Acute Pain 48 HCV Infection 48 GREEN BUILDING 47 AT HAND 47 Patient Empowerment 47 Childhood Trauma 47 Evaluable 47 Device Interoperability 47 Clinically Tested 47 Pathwork Tissue 47 Creates Opportunities 47 NONPROFIT 47 PLANETS 47 Detect Cancer 47 IN THE CLASSROOM 47 Immunogenic 47 EASTERN SHORE 47 Prednisone Against Refractory 47 Histologic 47 ORENCIA R 47 ON CLIMATE 47 Electrophysiological 47 #:#-#,# [002] 47 Results Indicate 47 serum prostate 47 Regression Analysis 47 Brain Stimulation 47 continuous hemoglobin SpHb 47 Radiation Dose 47 Anticancer Agents 47 ABRF 47 Alternative Treatments 47 Lipoprotein 47 Oligonucleotide 47 LUPUS 47 TOWN HALL MEETING 47 Patient Centered 47 PACIFIC NORTHWEST 47 Personalised Medicine 47 Platelet Aggregation 47 Prenatal Screening 47 Depressive Symptoms 47 Subtype 47 Assessment Questionnaire 47 MUSEUM OF HISTORY 47 AGENDA FOR 47 Cancer Vaccines 47 Inflammatory Response 47 Systematic Approach 47 Musculoskeletal Diseases 47 Genes Identified 47 EDICT 47 Processing Workstation 47 NTIOL 47 Colorectal Screening 47 Antidepressant Treatment 47 Cholinesterase Inhibitors 47 Pattern Generator 47 Practical Applications 47 Artificial Cornea 47 THEW 47 Biorepository 47 KID 'S 47 #:#-#,# Medline 47 CAUSE FOR 47 First Trimester 47 Practical Application 47 ANTARCTIC 47 Cognitive Disorders 47 Compendia Bioscience 47 Uric Acid 47 bronchoalveolar lavage 47 pain subscale 47 Multiscale 47 5K RUN WALK 47 Sequence Analysis 47 Slows Progression 47 Oxidized LDL 47 Postprandial 47 FRIENDS OF 47 Protein Protein Interactions 47 SMOKING CESSATION 47 Visual Analog 47 Cogn 47 Panic Disorder 47 Virologic Response